10/15/2026
๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช is more than a common stomach infection, itโs an important clinical condition that deserves appropriate testing and follow-up.
The latest global cancer analysis identified ๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช as a leading infectious contributor to cancer, linking the bacterium primarily to gastric cancers. These findings reinforce the importance of identifying active infection and confirming successful eradication after treatment.
A practical ๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช care pathway includes:
โข Test patients when clinically appropriate
โข Treat confirmed infection according to current guidelines
โข Confirm eradication after treatment
โข Take appropriate next steps when infection persists
BreathID supports noninvasive assessment of active ๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช infection and confirmation of eradication through a urea breath test.
is not a cancer-screening test. Its role is to help clinicians detect ๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช infection and verify whether treatment has been successful.
Read the full article and learn more about incorporating ๐. ๐ฑ๐บ๐ญ๐ฐ๐ณ๐ช testing and test-of-cure into clinical workflows: https://hubs.li/Q04zX6F10